Cargando…
Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors “leflunomide” and “teriflunomide” in Covid-19: A narrative review
Dihydroorotate dehydrogenase (DHODH) is rate-limiting enzyme in biosynthesis of pyrimidone which catalyzes the oxidation of dihydro-orotate to orotate. Orotate is utilized in the biosynthesis of uridine-monophosphate. DHODH inhibitors have shown promise as antiviral agent against Cytomegalovirus, Eb...
Autores principales: | Kaur, Hardeep, Sarma, Phulen, Bhattacharyya, Anusuya, Sharma, Saurabh, Chhimpa, Neeraj, Prajapat, Manisha, Prakash, Ajay, Kumar, Subodh, Singh, Ashutosh, Singh, Rahul, Avti, Pramod, Thota, Prasad, Medhi, Bikash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180448/ https://www.ncbi.nlm.nih.gov/pubmed/34111397 http://dx.doi.org/10.1016/j.ejphar.2021.174233 |
Ejemplares similares
-
Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2
por: Prajapat, Manisha, et al.
Publicado: (2020) -
Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach
por: Sarma, Phulen, et al.
Publicado: (2020) -
Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD
por: Chauhan, Arushi, et al.
Publicado: (2021) -
Update on geographical variation and distribution of SARS-nCoV-2: A systematic review
por: Prajapat, Manisha, et al.
Publicado: (2021) -
Drug targets for corona virus: A systematic review
por: Prajapat, Manisha, et al.
Publicado: (2020)